On September 23, 2014, DEA announced that its ninth Take Back Day would be the agency’s last. The announcement was made shortly after DEA published the Final Rule implementing the Secure and Responsible Drug Disposal Act of 2010. The regulations promulgated by DEA allow “authorized collectors” the opportunity to receive and securely dispose of prescription
In the Matter of Moore Clinical Trials, L.L.C (July 11, 2014)
DEA last month denied the DEA research registration application of an Arkansas clinical research company, finding that the person who would be primarily responsible for ordering and storing controlled substances had a “shocking” lack of knowledge of the fundamental requirements imposed by the Controlled
In the Matter of Hoi Y. Kam, M.D. (October 22, 2013)
In July 2011, the New York Department of Health revoked Dr. Hoi Kam’s medical license on the ground that he previously committed Medicaid fraud and had been excluded from the Medicaid program in 2006. Three months later, however, the State’s Administrative Review Board (ARB)
In the Matter of Joe W. Morgan, D.O. (October 8, 2013)
On April 9, 2012, the DEA issued an Order to Show Cause proposing the revocation of Joe W. Morgan, D.O.’s DEA registration based on his alleged prescribing of controlled substances in “dangerous and excessive,” and potentially lethal, quantities. Dr. Morgan was a DEA-registered physician
In the Matter of Kenneth Harold Bull, M.D. (October 22, 2013)
Dr. Kenneth Bull is a New Mexico psychiatrist known for treating difficult or complex psychiatric conditions. During his long career, Dr. Bull worked as the chief of psychiatry or medical director of psychiatric services at nearly every hospital in the Albuquerque area, and he
In the Matter of Anthony E. Wicks, M.D. (October 22, 2013)
DEA refused to issue a new DEA registration to a doctor who moved from California to central Florida in December 2010 and, in the seven months after his move, wrote more than 2,000 controlled substance prescriptions from his new location without notifying DEA of
In the Matter of Clair L. Pettinger, M.D. (October 3, 2013)
On nine occasions between November 10, 2011 and May 9, 2012, Clair L. Pettinger, M.D. issued prescriptions for controlled substances to undercover law enforcement agents. During these visits Dr. Pettinger failed to conduct sufficient medical examinations, failed to make diagnoses of the medical conditions
In the Matter of Gabriel Sanchez, M.D. (September 25, 2013)
On July 15 2010, Dr. Gabriel Sanchez issued prescriptions for oxycodone (Schedule II) and carisoprodol (Schedule IV) to two undercover law enforcement officers. During the visits with both undercover officers, Dr. Sanchez failed to take complete medical histories, failed to make serious inquiries into the
In the Matter of S&S Pharmacy, Inc., d/b/a Platinum Pharmacy & Compounding (Sept. 19, 2013) In 2011, Ihab S. Barsoum, the owner and pharmacist-in-charge of S&S Pharmacy, Inc., d/b/a Platinum Pharmacy & Compounding (“Platinum Pharmacy”), engaged in what the Administrator described as “blatant drug deal(s) and [] distribution(s).” On five occasions between January and June
In the Matter of Kevin Dennis, M.D. (August 26, 2013) 
In 2007, Dr. Kevin Dennis became involved with an Internet prescribing company known as “Telemed Ventures.” Between 2007 and 2008, Dr. Dennis (who was licensed and registered in Tennessee only) issued numerous prescriptions to individuals located in other states without seeing them or performing any